Osaic Holdings’s Rani Therapeutics RANI Stock Holding History

Osaic Holdings’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.88K	Buy	+3,787	New	+$3.36K	﹤0.01%	7155
2026 Q1	–	Sell	-1,000	Closed	-$1.35K	–	8020
2025 Q4	$1.35K	Hold	1,000	–	–	﹤0.01%	7192
2025 Q3	$490	Sell	1,000 -5,668	-85%	-$2.95K	﹤0.01%	7552
2025 Q2	$3.4K	Hold	6,668	–	–	﹤0.01%	6742
2025 Q1	$8.4K	Buy	6,668 +5,168	+345%	+$7.65K	﹤0.01%	5884
2024 Q4	$2.06K	Buy	+1,500	New	+$3.15K	﹤0.01%	6590
2022 Q3	–	Sell	-19,012	Closed	-$196K	–	7461
2022 Q2	$196K	Sell	19,012 -331	-2%	-$3.8K	﹤0.01%	3818
2022 Q1	$261K	Sell	19,343 -1,729	-8%	-$28.7K	﹤0.01%	3797
2021 Q4	$344K	Buy	+21,072	New	+$479K	﹤0.01%	3426

Other funds holding RANI

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Osaic Holdings's RANI Position: Q2 2026 in Review

Osaic Holdings opened a new position in Rani Therapeutics (RANI) in Q2 2026: 3,787 shares worth $2.88K. The stake represents ﹤0.01% of the portfolio and ranks #7155 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in RANI as recently as Q4 2025.

Osaic Holdings first reported a position in RANI in Q4 2021 and has held it in 9 quarters since. The position peaked at $344K in Q4 2021. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

Osaic Holdings held 3,787 shares of Rani Therapeutics worth $2.88K as of Q2 2026.
Rani Therapeutics was a new Osaic Holdings position in Q2 2026.
Rani Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7155 holding.
Osaic Holdings first reported a position in Rani Therapeutics in Q4 2021 and has held it in 9 quarters since.
Osaic Holdings's Rani Therapeutics position peaked at $344K in Q4 2021.
68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.